Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
Year: 2025
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.16443
Institution: Gilead Sciences (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Gilead Sciences
OpenAlex ID: W4410414956
